ticlopidine has been researched along with Autoimmune Disease in 6 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Excerpt | Relevance | Reference |
---|---|---|
" The purpose of this study was to define the background characteristics of patients with microscopic colitis, as well as to present symptoms, coexistent autoimmune diseases, and a possible association with the use of non-steroidal anti-inflammatory drugs (NSAIDs) and ticlopidine." | 3.73 | Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation. ( Chande, N; Driman, DK; Reynolds, RP, 2005) |
"Thrombotic thrombocytopenic purpura is a thrombotic microangiopathy related to a severe deficiency of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13; activity <10%)." | 2.82 | Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. ( Azoulay, E; Benhamou, Y; Boisseau, P; Coppo, P; de Maistre, E; Delmas, Y; Galicier, L; Mariotte, E; Perez, P; Poullin, P; Provôt, F; Rondeau, E; Stepanian, A; Veyradier, A; Zouiti, F, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Yang, CC | 1 |
Gu, WJ | 1 |
Lyu, ZH | 1 |
Cheng, Y | 1 |
Jia, AH | 1 |
Dou, JT | 1 |
Ba, JM | 1 |
Mu, YM | 1 |
Qin, C | 1 |
Zhou, J | 1 |
Gao, Y | 1 |
Lai, W | 1 |
Yang, C | 1 |
Cai, Y | 1 |
Chen, S | 1 |
Du, C | 1 |
Yamada, E | 1 |
Okada, S | 1 |
Saito, T | 1 |
Osaki, A | 1 |
Ozawa, A | 1 |
Yamada, M | 1 |
Mariotte, E | 1 |
Azoulay, E | 1 |
Galicier, L | 1 |
Rondeau, E | 1 |
Zouiti, F | 1 |
Boisseau, P | 1 |
Poullin, P | 1 |
de Maistre, E | 1 |
Provôt, F | 1 |
Delmas, Y | 1 |
Perez, P | 1 |
Benhamou, Y | 1 |
Stepanian, A | 1 |
Coppo, P | 1 |
Veyradier, A | 1 |
Hayashi, K | 1 |
Ohtsu, F | 1 |
Yano, R | 1 |
Sakakibara, J | 1 |
Goto, N | 1 |
Chande, N | 1 |
Driman, DK | 1 |
Reynolds, RP | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
ADAMTS13-related Prognostic Factors in Adult and Pediatric Thrombotic Thrombocytopenic Purpura[NCT00426686] | 153 participants (Actual) | Observational | 2006-11-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ticlopidine and Autoimmune Disease
Article | Year |
---|---|
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Topics: ADAMTS13 Protein; Adult; Autoantibodies; Autoimmune Diseases; Clopidogrel; Cohort Studies; Cross-Sec | 2016 |
5 other studies available for ticlopidine and Autoimmune Disease
Article | Year |
---|---|
[One case report of insulin autoimmune syndrome induced by clopidogrel].
Topics: Autoimmune Diseases; Clopidogrel; Humans; Insulins; Platelet Aggregation Inhibitors; Ticlopidine | 2021 |
Critical Role of P2Y
Topics: Adenosine; Animals; Autoimmune Diseases; Cell Differentiation; Cells, Cultured; Clopidogrel; Colitis | 2017 |
Insulin autoimmune syndrome during the administration of clopidogrel.
Topics: Aged; Aged, 80 and over; Autoantibodies; Autoimmune Diseases; Blood Glucose; Clopidogrel; Glycated H | 2016 |
[Risk factors and subjective symptoms of drug-induced leucopenia].
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Autoimmune Dise | 2011 |
Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Biopsy | 2005 |